Mehta, P., Thummar, V. and Bhavsar, H. 2026. Clinical outcomes of neoadjuvant dual HER2 blockade with pertuzumab/Sigrima and trastuzumab/Vivitra biosimilars: real-world evidence in HER2-positive breast cancer in India. International Journal of Research in Medical Sciences. 14, 4 (Mar. 2026), 1584–1588. DOI:https://doi.org/10.18203/2320-6012.ijrms20260973.